title: Twenty years of boosting antiretroviral agents: where are we today?
authors.affiliation: aSt Stephen's AIDS Trust, Chelsea and Westminster Hospital bImperial College, London cUniversity of Liverpool, Liverpool, UK dInfectious Diseases and AIDS Units, Hospital Clinic/IDIBAPS and University of Barcelona, Barcelona, Spain.
authors.forename: Marta
authors.initials: M
authors.lastname: Boffito
authors.forename: David
authors.initials: D
authors.lastname: Back
authors.forename: José M
authors.initials: JM
authors.lastname: Gatell
mesh_terms: D044966:Anti-Retroviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010949:Plasma / Q000737:chemistry; D019438:Ritonavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D019258:Saquinavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D044966:Anti-Retroviral Agents; D019258:Saquinavir; D019438:Ritonavir